InMode - INMD Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for InMode in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INMD shares.
View INMD analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 12-month target prices for InMode's shares. Their INMD share price forecasts range from $40.00 to $60.00. On average, they predict the company's stock price to reach $46.60 in the next year. This suggests a possible upside of 31.2% from the stock's current price.
View analysts price targets for INMD or view top-rated stocks among Wall Street analysts.

InMode's stock was trading at $70.58 at the start of the year. Since then, INMD stock has decreased by 49.7% and is now trading at $35.53.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023.
View our INMD earnings forecast.

InMode Ltd. (NASDAQ:INMD) announced its quarterly earnings data on Tuesday, October, 26th. The healthcare company reported $0.55 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.05. The healthcare company had revenue of $94.18 million for the quarter, compared to analyst estimates of $89.38 million. InMode had a net margin of 40.93% and a trailing twelve-month return on equity of 39.52%. The firm's revenue was up 57.7% on a year-over-year basis. During the same period last year, the company earned $0.31 EPS.

Shares of InMode split on Thursday, September 30th 2021. The 2-1 split was announced on Friday, September 17th 2021. The newly issued shares were distributed to shareholders after the market closes on Monday, September 27th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

InMode issued an update on its FY 2022 earnings guidance on Thursday, November, 3rd. The company provided earnings per share (EPS) guidance of $2.28-$2.30 for the period, compared to the consensus estimate of $2.22. The company issued revenue guidance of $445.00 million-$450.00 million, compared to the consensus revenue estimate of $440.81 million.

1 employees have rated InMode Chief Executive Officer Moshe Mizrahy on Glassdoor.com. Moshe Mizrahy has an approval rating of 100% among the company's employees. This puts Moshe Mizrahy in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other InMode investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Micron Technology (MU), AbbVie (ABBV), Advanced Micro Devices (AMD), Block (SQ), Tesla (TSLA), DocuSign (DOCU) and PayPal (PYPL).

(INMD) raised $75 million in an initial public offering (IPO) on Thursday, August 8th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. ​Barclays, UBS Investment Bank and Canaccord Genuity acted as the underwriters for the IPO and Baird was co-manager.

InMode trades on the NASDAQ under the ticker symbol "INMD."

InMode's stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (2.76%), BlackRock Inc. (2.25%), Meitav Dash Investments Ltd. (1.96%), Two Sigma Advisers LP (1.28%), Point72 Asset Management L.P. (1.23%) and Migdal Insurance & Financial Holdings Ltd. (1.01%).

Shares of INMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of INMD stock can currently be purchased for approximately $35.53.

InMode (NASDAQ:INMD) has a market capitalization of $2.96 billion and generates $357.57 million in revenue each year. The healthcare company earns $164.97 million in net income (profit) each year or $2.07 on an earnings per share basis.

The company employs 362 workers across the globe.

InMode's mailing address is TAVOR BUILDING SHAAR YOKNEAM POB 533, YOKNEAM L3, 2069200. The official website for the company is www.inmodemd.com. The healthcare company can be reached via phone at 972-4909-7470 or via email at ir@inmodemd.com.